These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
204 related items for PubMed ID: 9699648
21. Frequent somatic loss of BRCA1 in breast tumours from BRCA2 germ-line mutation carriers and vice versa. Staff S, Isola JJ, Johannsson O, Borg A, Tanner MM. Br J Cancer; 2001 Oct 19; 85(8):1201-5. PubMed ID: 11710835 [Abstract] [Full Text] [Related]
22. High incidence of protein-truncating TP53 mutations in BRCA1-related breast cancer. Holstege H, Joosse SA, van Oostrom CT, Nederlof PM, de Vries A, Jonkers J. Cancer Res; 2009 Apr 15; 69(8):3625-33. PubMed ID: 19336573 [Abstract] [Full Text] [Related]
23. Identification of germline BRCA1 and BRCA2 genetic alterations in Greek breast cancer moderate-risk and low-risk individuals--correlation with clinicopathological data. Kataki A, Gomatos I, Pararas N, Armakolas A, Panousopoulos D, Karantzikos G, Voros D, Zografos G, Markopoulos C, Leandros E, Konstadoulakis M. Clin Genet; 2005 Apr 15; 67(4):322-9. PubMed ID: 15733268 [Abstract] [Full Text] [Related]
24. Ashkenazi founder BRCA1/BRCA2 mutations in Slovak hereditary breast and/or ovarian cancer families. Cierniková S, Tomka M, Kovác M, Stevurková V, Zajac V. Neoplasma; 2006 Apr 15; 53(2):97-102. PubMed ID: 16575464 [Abstract] [Full Text] [Related]
25. [Mutational analysis of breast/ovarian cancer hereditary predisposition gene BRCA1 in Tunisian women]. Mestiri S, Monastiri K, Ben Ahmed S, Bouaouina N, Presneau N, Bignon YJ, Khairi H, Chouchane L. Arch Inst Pasteur Tunis; 2000 Apr 15; 77(1-4):11-5. PubMed ID: 14658222 [Abstract] [Full Text] [Related]
26. Germline BRCA1-2 mutations in non-Ashkenazi families with double primary breast and ovarian cancer. Schorge JO, Mahoney NM, Miller DS, Coleman RL, Muller CY, Euhus DM, Tomlinson GE. Gynecol Oncol; 2001 Nov 15; 83(2):383-7. PubMed ID: 11606101 [Abstract] [Full Text] [Related]
27. Population-based estimate of the average age-specific cumulative risk of breast cancer for a defined set of protein-truncating mutations in BRCA1 and BRCA2. Australian Breast Cancer Family Study. Hopper JL, Southey MC, Dite GS, Jolley DJ, Giles GG, McCredie MR, Easton DF, Venter DJ. Cancer Epidemiol Biomarkers Prev; 1999 Sep 15; 8(9):741-7. PubMed ID: 10498392 [Abstract] [Full Text] [Related]
28. Loss of heterozygosity analysis in ductal lavage samples from BRCA1 and BRCA2 carriers: a cautionary tale. Antill YC, Mitchell G, Johnson SA, Devereux L, Milner A, Phillips KA, Campbell IG. Cancer Epidemiol Biomarkers Prev; 2006 Jul 15; 15(7):1396-8. PubMed ID: 16835342 [Abstract] [Full Text] [Related]
29. Germline BRCA1 mutations and G/C polymorphism in the 5'-untranslated region of the RAD51 gene in Polish women with breast cancer. Romanowicz-Makowska H, Smolarz B, Kulig A. Pol J Pathol; 2005 Jul 15; 56(4):161-5. PubMed ID: 16477874 [Abstract] [Full Text] [Related]
30. Heterogenic loss of the wild-type BRCA allele in human breast tumorigenesis. King TA, Li W, Brogi E, Yee CJ, Gemignani ML, Olvera N, Levine DA, Norton L, Robson ME, Offit K, Borgen PI, Boyd J. Ann Surg Oncol; 2007 Sep 15; 14(9):2510-8. PubMed ID: 17597348 [Abstract] [Full Text] [Related]
31. BRCA1 mutations and polymorphisms in a hospital-based consecutive series of breast cancer patients from Apulia, Italy. Tommasi S, Crapolicchio A, Lacalamita R, Bruno M, Monaco A, Petroni S, Schittulli F, Longo S, Digennaro M, Calistri D, Mangia A, Paradiso A. Mutat Res; 2005 Oct 15; 578(1-2):395-405. PubMed ID: 16026807 [Abstract] [Full Text] [Related]
32. Establishment and characterization of a schwannoma cell line from a patient with neurofibromatosis 2. Hung G, Li X, Faudoa R, Xeu Z, Kluwe L, Rhim JS, Slattery W, Lim D. Int J Oncol; 2002 Mar 15; 20(3):475-82. PubMed ID: 11836557 [Abstract] [Full Text] [Related]
33. Epigenetic silencing and deletion of the BRCA1 gene in sporadic breast cancer. Birgisdottir V, Stefansson OA, Bodvarsdottir SK, Hilmarsdottir H, Jonasson JG, Eyfjord JE. Breast Cancer Res; 2006 Mar 15; 8(4):R38. PubMed ID: 16846527 [Abstract] [Full Text] [Related]
34. BRCA1 germline mutations in Cypriot breast cancer patients from 26 families with family history. Hadjisavvas A, Neuhausen SL, Hoffman MD, Adamou A, Newbold RF, Kyriacou KC, Christodoulou CG. Anticancer Res; 2001 Mar 15; 21(5):3307-11. PubMed ID: 11848488 [Abstract] [Full Text] [Related]
35. [Analysis of loss of heterozygosity and microsatellite instability RAD52, RAD54 and RAD54B gene and BRCA1 gene mutation in breast cancer]. Romanowicz-Makowska H, Smolarz B. Pol Merkur Lekarski; 2006 Dec 15; 21(126):548-50. PubMed ID: 17405295 [Abstract] [Full Text] [Related]
36. Molecular profiles of BRCA1-mutated and matched sporadic breast tumours: relation with clinico-pathological features. Berns EM, van Staveren IL, Verhoog L, van de Ouweland AM, Meijer-van Gelder M, Meijers-Heijboer H, Portengen H, Foekens JA, Dorssers LC, Klijn JG. Br J Cancer; 2001 Aug 17; 85(4):538-45. PubMed ID: 11506493 [Abstract] [Full Text] [Related]
38. Functional characterization of a novel BRCA1-null ovarian cancer cell line in response to ionizing radiation. DelloRusso C, Welcsh PL, Wang W, Garcia RL, King MC, Swisher EM. Mol Cancer Res; 2007 Jan 17; 5(1):35-45. PubMed ID: 17259345 [Abstract] [Full Text] [Related]
39. BRCA1 mutations in familial ovarian cancer. Lallas TA, Buekers TE, Buller RE. Mol Genet Metab; 1999 Aug 17; 67(4):357-63. PubMed ID: 10444347 [Abstract] [Full Text] [Related]
40. Implication of BRCA1 gene in breast cancer. Kachhap SK, Ghosh SN. Indian J Exp Biol; 2001 May 17; 39(5):391-400. PubMed ID: 11510120 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]